We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
FLUCLOXACILLIN BAXTER (Baxter Healthcare Pty Ltd)
Product name
FLUCLOXACILLIN BAXTER
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
132 (255 working days)
Active ingredients
flucloxacillin sodium monohydrate
Registration type
New generic medicine
Indication
For the treatment of confirmed or suspected Staphylococcal and other Gram-positive coccal infections. Indications include pneumonia, osteomyelitis, skin and skin structure and wound infections, infected burns and cellulitis.